The Oncology Institute, Inc. TOI Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from The Oncology Institute, Inc.’s reported figures.
Based on the most recent quarter.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s cash ratio?
- The Oncology Institute, Inc. (TOI) reported cash ratio of 0.4× in Q1 2026.
- How has The Oncology Institute, Inc.'s cash ratio changed year-over-year?
- The Oncology Institute, Inc.'s cash ratio decreased by 42.8% year-over-year, from 0.7× to 0.4×.
- What is the long-term trend for The Oncology Institute, Inc.'s cash ratio?
- Over 5 years (2020 to 2025), The Oncology Institute, Inc.'s cash ratio has grown at a 71.3% compound annual growth rate (CAGR), from 0× to 0.5×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.